Compare MP Materials (MP) vs Moderna, Inc. (MRNA) Price & Performance

MP MaterialsTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

MP Materials vs Moderna, Inc. — how do they compare? MP Materials trades at $46.14 (market cap $8.22B), while Moderna, Inc. trades at $225 (market cap $78.65B). The key difference: Moderna, Inc. is far larger — about 9.6× MP Materials's market cap, and Moderna, Inc. is trading nearer its 52-week high, MP Materials nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MP Materials for 11 Days and Moderna, Inc. for 59 Days on average.

	MP	MRNA
Market Cap	$8.22B	$78.65B
Volume	5,457,792	37,373,437
Sector	Basic Materials	Health
52-Week High	$98.65	$203.46
52-Week Low	$38.10	$22.36
Typical Hold Time	11 Days	59 Days
Enterprise Value	$7.70B	$74.80B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MP Materials

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $197.00, up 0.26% on the day, with technical indicators showing a bullish trend and strong momentum. The stock has rallied over 500% in 2026, driven by positive clinical updates for its cancer vaccine pipeline and inclusion in the Nasdaq-100 index effective October 9, 2026. However, fundamentals remain challenging with revenue declining from $18.9B in 2022 to $1.9B in 2025 and negative net income margins exceeding 140%.

While technical momentum and pipeline optimism support near-term upside, valuation appears stretched with P/S of 35.08 and negative profitability metrics. Key risks include execution on non-COVID products, competitive pressure, and sustainability of recent gains. Analyst consensus is cautious with only 28% buy ratings and $115.70 price target suggesting significant downside from current levels.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

93% Buy7% Sell

Avg holding period · 11 Days

MRNA

53% Buy47% Sell

Avg holding period · 59 Days

Top news

Latest headlines on both assets

Critical metals stocks fall again; builders like USA Rare Earth drop sharply, producers like MP Materials hold better.24/7 Wall Street · 1 day agoBearish Rare earth stocks drop 3-5% amid sector-wide selloff without company-specific news.24/7 Wall Street · 2 days agoBearish Pentagon invests $400M in MP Materials to break China's rare earth magnet monopoly, GM first to receive non-China magnets.24/7 Wall Street · 4 days agoBullish View details →

MRNA

Novavax jumps 16% amid biotech rally, outpacing Moderna and Merck despite no new company news.24/7 Wall Street · 10 hours agoBullish Moderna jumps 5% on NASDAQ 100 inclusion, outpacing Pfizer and BioNTech amid oncology pipeline optimism.24/7 Wall Street · 13 hours agoBullish Moderna stock surges 545% in 2026, investors face choice to take profits or hold for pipeline growth.24/7 Wall Street · 3 days agoBullish View details →

About MP Materials

MP Materials mines, refines, and manufactures rare earth materials and magnets in the United States. Its products are used in transportation, energy, robotics, defense, and aerospace applications.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.